Related references
Note: Only part of the references are listed.Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Robert S. Svatek et al.
EUROPEAN UROLOGY (2014)
A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer
Anirban P. Mitra et al.
BJU INTERNATIONAL (2013)
Cost-effective treatment of low-risk carcinoma not invading bladder muscle
David A. Green et al.
BJU INTERNATIONAL (2013)
Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy
Zachary L. Smith et al.
BJU INTERNATIONAL (2013)
Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?
Kathie A. Wong et al.
BJU INTERNATIONAL (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Recommendations on Bladder Cancer-Progress in a Cancer that Lacks the Limelight
Mark S. Soloway
EUROPEAN UROLOGY (2013)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Marko Babjuk et al.
EUROPEAN UROLOGY (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2013)
Cost-Effectiveness of Fluorescence In Situ Hybridization in Patients with Atypical Cytology for the Detection of Urothelial Carcinoma
Bishoy A. Gayed et al.
JOURNAL OF UROLOGY (2013)
COST EFFECTIVENESS ANALYSIS OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
Scott Stevenson et al.
JOURNAL OF UROLOGY (2013)
FGFR3 Mutation Analysis in Voided Urine Samples to Decrease Cystoscopies and Cost in Nonmuscle Invasive Bladder Cancer Surveillance: A Comparison of 3 Strategies
Kim E. M. van Kessel et al.
JOURNAL OF UROLOGY (2013)
The Costs of Non-Muscle Invasive Bladder Cancer
Andrew C. James et al.
UROLOGIC CLINICS OF NORTH AMERICA (2013)
Cost Analysis of Open Radical Cystectomy Versus Robot-assisted Radical Cystectomy
Chinedu O. Mmeje et al.
CURRENT UROLOGY REPORTS (2013)
A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding
Ashley J. R. Carter et al.
BMC PUBLIC HEALTH (2012)
Comparative Analysis of Outcomes and Costs Following Open Radical Cystectomy Versus Robot-Assisted Laparoscopic Radical Cystectomy: Results From the US Nationwide Inpatient Sample
Hua-yin Yu et al.
EUROPEAN UROLOGY (2012)
The Implications of Hospital Acquired Adverse Events on Mortality, Length of Stay and Costs for Patients Undergoing Radical Cystectomy for Bladder Cancer
Simon P. Kim et al.
JOURNAL OF UROLOGY (2012)
Economic and Humanistic Consequences of Preventable Bladder Tumor Recurrences in Nonmuscle Invasive Bladder Cancer Cases
Cheryl T. Lee et al.
JOURNAL OF UROLOGY (2012)
Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples
Lukas Jyuhn-Hsiarn Lee et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2012)
Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity
Ashish M. Kamat et al.
BJU INTERNATIONAL (2011)
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy
Richard Lee et al.
BJU INTERNATIONAL (2011)
Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC
Richard Lee et al.
BJU INTERNATIONAL (2011)
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Complete Cost Analysis
Aaron D. Martin et al.
UROLOGY (2011)
Screening Adults for Bladder Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2010)
The Effect of Changes in Medicare Reimbursement on the Practice of Office and Hospital-Based Endoscopic Surgery for Bladder Cancer
Micah L. Hemani et al.
CANCER (2010)
Understanding the Variation in Treatment Intensity Among Patients With Early Stage Bladder Cancer
John M. Hollingsworth et al.
CANCER (2010)
The Excessive Cost of Early Stage Bladder Cancer Care Are Providers Really to Blame?
Micah L. Hemani et al.
CANCER (2010)
Patterns of Care for Early Stage Bladder Cancer
Seth A. Strope et al.
CANCER (2010)
Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort
Hans-Martin Fritsche et al.
EUROPEAN UROLOGY (2010)
Cost Analysis of Robotic Versus Open Radical Cystectomy for Bladder Cancer
Angela Smith et al.
JOURNAL OF UROLOGY (2010)
Urine Cytology in the Evaluation of Urological Malignancy Revisited: Is It Still Necessary?
Opeyemi Adegboyega Falebita et al.
UROLOGIA INTERNATIONALIS (2010)
Utility of Urine Cytology in the Workup of Asymptomatic Microscopic Hematuria in Low-risk Patients
Andrew H. Feifer et al.
UROLOGY (2010)
Contemporary Cost Analysis of Single Instillation of Mitomycin After Transurethral Resection of Bladder Tumor in a Universal Health Care System
Andrew Feifer et al.
UROLOGY (2010)
Radical Cystectomy with Orthotopic Neobladder for Invasive Bladder Cancer: A Critical Analysis of Long Term Oncological, Functional and Quality of Life Results
Arnulf Stenzl et al.
INTERNATIONAL BRAZ J UROL (2010)
Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?
Esther W. de Bekker-Grob et al.
BJU INTERNATIONAL (2009)
Routine Perioperative Chemotherapy Instillation With Initial Bladder Tumor Resection A Reconsideration of Economic Benefits
Pravin K. Rao et al.
CANCER (2009)
Treatment of Nonmuscle Invading Bladder Cancer: Do Physicians in the United States Practice Evidence Based Medicine? The Use and Economic Implications of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumors
Ralph Madeb et al.
CANCER (2009)
Cost-Effectiveness Analysis of Immediate Radical Cystectomy Versus Intravesical Bacillus Calmette-Guerin Therapy for High-Risk, High-Grade (T1G3) Bladder Cancer
Girish S. Kulkarni et al.
CANCER (2009)
Time Costs Associated With Informal Caregiving for Cancer Survivors
K. Robin Yabroff et al.
CANCER (2009)
Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder Cancer
Brent K. Hollenbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumor Marker
Yair Lotan et al.
JOURNAL OF UROLOGY (2009)
Effect of Postcystectomy Infectious Complications on Cost, Length of Stay, and Mortality
Benjamin J. Davies et al.
UROLOGY (2009)
Quality of Life and Body Image for Bladder Cancer Patients Undergoing Radical Cystectomy and Urinary Diversion-A Prospective Cohort Study With a Systematic Review of Literature
Bhaskar K. Somani et al.
UROLOGY (2009)
Economic aspects of bladder cancer: what are the benefits and costs?
K. D. Sievert et al.
WORLD JOURNAL OF UROLOGY (2009)
The present and future burden of urinary bladder cancer in the world
Martine Ploeg et al.
WORLD JOURNAL OF UROLOGY (2009)
Commentary: the role of cytologic analysis of voided urine in the work-up of asymptomatic microhematuria
Deep Trivedi et al.
BMC Urology (2009)
The economic burden of cancer in Korea in 2002
S. -G. Kim et al.
EUROPEAN JOURNAL OF CANCER CARE (2008)
Bladder Cancer: A Major Public Health Issue
Marco Grasso
EUROPEAN UROLOGY SUPPLEMENTS (2008)
Cost of care for elderly cancer patients in the United States
K. Robin Yabroff et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Predictors of intravesical therapy for nonmuscle invasive bladder cancer: Results from the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care Project
George J. Huang et al.
JOURNAL OF UROLOGY (2008)
Clinical model of cost of bladder cancer in the elderly
Catherine D. Cooksley et al.
UROLOGY (2008)
Is routine urine cytology useful in the haematuria clinic?
S. Viswanath et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2008)
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
M. Craig Hall et al.
JOURNAL OF UROLOGY (2007)
The use of local Anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: Preliminary results and cost-effectiveness analysis
Maurizio A. Brausi et al.
EUROPEAN UROLOGY (2007)
Optimal management of high-risk T1G3 bladder cancer: A decision analysis
Girish S. Kulkarni et al.
PLOS MEDICINE (2007)
Photodynamic diagnostics and noninvasive bladder cancer: Is it cost-effective in long-term application? A Germany-based cost analysis
Maximilian Burger et al.
EUROPEAN UROLOGY (2007)
Bladder and upper tract urothelial cancer
Badrinath R. Konety et al.
JOURNAL OF UROLOGY (2007)
Intravesical instillation of bacille Calmette-Guerin for superficial bladder cancer: Cost-effectiveness analysis
Atsushi Uchida et al.
UROLOGY (2007)
Patient time costs associated with cancer care
K. Robin Yabroff et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Discrepancy between clinical and pathologic stage: Impact on prognosis after radical cystectomy
Shahrokh F. Shariat et al.
EUROPEAN UROLOGY (2007)
Influence of post-cystectomy complications on cost and subsequent outcome
Badrinath R. Konety et al.
JOURNAL OF UROLOGY (2007)
Long-term outcome of hematuria home screening for bladder cancer in men
Edward M. Messing et al.
CANCER (2006)
Clinical model of lifetime cost of treating bladder cancer and associated complications
Elenir B. C. Avritscher et al.
UROLOGY (2006)
Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis
Yair Lotan et al.
CANCER (2006)
Economic impact of screening for bladder cancer using bladder tumor markers: A decision analysis
Robert S. Svatek et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: Data from the surveillance, epidemiology, and end results program
BR Konety et al.
JOURNAL OF UROLOGY (2005)
Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: Impact on patient outcomes and costs
AT Ludwig et al.
UROLOGY (2005)
Costs of radical cystectomy
I Berrum-Svennung et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2005)
The economic consequences of prostate and bladder cancer in the UK
VK Sangar et al.
BJU INTERNATIONAL (2005)
Association between volume and charges for most frequently performed ambulatory and nonambulatory surgery for bladder cancer. Is more cheaper?
BR Konety et al.
JOURNAL OF UROLOGY (2004)
Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia
M Jonler et al.
BJU INTERNATIONAL (2004)
Is cytology required for a hematuria evaluation?
CA Hofland et al.
JOURNAL OF UROLOGY (2004)
Is there standard chemotherapy for metastatic bladder cancer?: Quality of life and medical resources utilization based on largest to date randomized trial
J Lehmann et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
The health economics of bladder cancer - A comprehensive review of the published literature
MF Botteman et al.
PHARMACOECONOMICS (2003)
The cost of bladder tumour treatment and follow-up
H Hedelin et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2002)
Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: A decision analytical approach
Y Lotan et al.
JOURNAL OF UROLOGY (2002)
Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma
BS Chang et al.
UROLOGY (2001)
Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association Best Practice Policy - Part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up
GD Grossfeld et al.
UROLOGY (2001)
Complications for radical cystectomy - Impact of the American Society of Anesthesiologists score
B Malavaud et al.
EUROPEAN UROLOGY (2001)
The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: A combined analysis of 5 European organization for research and treatment of cancer trials
A Van Der Meijden et al.
JOURNAL OF UROLOGY (2000)
Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis
RK Nam et al.
JOURNAL OF UROLOGY (2000)
Share Paper
